Indonesia has secured a $30 million investment from Japanese pharmaceutical company Takeda to establish a plasma-derived medicine production network. This marks the first phase of a two-year initiative to create a national plasma bank system, aiming to enhance domestic capabilities in the sector. The project includes technology transfer, workforce training, and job creation, according to Investment and Downstreaming Minister Rosan Roeslani. The first plasma bank is expected to operate by 2027. Japan is a major investor in Indonesia, contributing $1 billion in Q1 2026 alone, with cumulative investments totaling $18.1 billion between 2021 and early 2026.
Bias read (Center): The article presents a factual report on a foreign investment agreement involving government policy and economic development. It emphasizes collaboration between the Indonesian government and a private Japanese firm, with quotes from an official and mentions alignment with national strategies. There


